QQ客服 官方微博 反馈留言

	Selenadiazole derivatives antagonize hyperglycemia-induced drug resistance in breast cancer cells by activation of AMPK pathways
	Zhao, Jianfu[1,2]; Zeng, Delong[1]; Liu, Yuedan[1]; Luo, Yi[1]; Ji, Shengbin[1]; Li, Xiaoling[3]; Chen, Tianfeng[1]
	2017
卷号	9期号:5页码:535
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4318601
专题	暨南大学
作者单位	1.[1]Jinan Univ, Dept Chem, Guangzhou 510632, Guangdong, Peoples R China 2.[2]Jinan Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China 3.[3]Jinan Univ, Inst Food Safety & Nutr, Guangzhou, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Zhao, Jianfu[1,2],Zeng, Delong[1],Liu, Yuedan[1],et al. Selenadiazole derivatives antagonize hyperglycemia-induced drug resistance in breast cancer cells by activation of AMPK pathways[J],2017,9(5):535.
APA	Zhao, Jianfu[1,2].,Zeng, Delong[1].,Liu, Yuedan[1].,Luo, Yi[1].,Ji, Shengbin[1].,...&Chen, Tianfeng[1].(2017).Selenadiazole derivatives antagonize hyperglycemia-induced drug resistance in breast cancer cells by activation of AMPK pathways.,9(5),535.
MLA	Zhao, Jianfu[1,2],et al."Selenadiazole derivatives antagonize hyperglycemia-induced drug resistance in breast cancer cells by activation of AMPK pathways".9.5(2017):535.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。